GB1495159A - Process reducing the anticomplementary activity of gamma globulins - Google Patents
Process reducing the anticomplementary activity of gamma globulinsInfo
- Publication number
- GB1495159A GB1495159A GB53020/75A GB5302075A GB1495159A GB 1495159 A GB1495159 A GB 1495159A GB 53020/75 A GB53020/75 A GB 53020/75A GB 5302075 A GB5302075 A GB 5302075A GB 1495159 A GB1495159 A GB 1495159A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gamma globulin
- solution
- centrifuged
- precipitated
- hydroxyethyl starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2500076A DE2500076C3 (de) | 1975-01-02 | 1975-01-02 | Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1495159A true GB1495159A (en) | 1977-12-14 |
Family
ID=5935911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB53020/75A Expired GB1495159A (en) | 1975-01-02 | 1975-12-29 | Process reducing the anticomplementary activity of gamma globulins |
Country Status (20)
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980002374A1 (en) * | 1979-05-10 | 1980-11-13 | American Hospital Supply Corp | Hydroxyalkyl starch drug carrier |
| EP0073371A2 (en) * | 1981-08-24 | 1983-03-09 | Miles Laboratories, Inc. | Intravenously injectable immune serum globulin and method of preparing same |
| EP1190719A1 (de) * | 2000-08-17 | 2002-03-27 | B. Braun Melsungen Ag | Kolloidale Pharmakomodulation injizierter Arzneimittel |
| US8497072B2 (en) | 2005-11-30 | 2013-07-30 | Abbott Laboratories | Amyloid-beta globulomer antibodies |
| US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
| US8877190B2 (en) | 2006-11-30 | 2014-11-04 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US9176150B2 (en) | 2003-01-31 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2604759C2 (de) * | 1976-02-07 | 1983-06-01 | SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld | Verfahren zur Gewinnung von iv-verträglichen Γglobulinen |
| JPS6016406B2 (ja) * | 1976-08-06 | 1985-04-25 | マイヤ−、ル−イス、コ−バル | 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン |
| US4124576A (en) * | 1976-12-03 | 1978-11-07 | Coval M L | Method of producing intravenously injectable gamma globulin |
| GB1603244A (en) * | 1977-05-20 | 1981-11-18 | Max Planck Gesellschaft | Medicaments for the suppression of pathological processes |
| JPS5822085B2 (ja) * | 1977-07-19 | 1983-05-06 | 株式会社ミドリ十字 | 静注用ガンマ・グロブリン製剤 |
| AT359641B (de) * | 1978-09-19 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates |
| DE3271181D1 (en) * | 1982-02-08 | 1986-06-19 | Schweiz Serum & Impfinst | Intravenously administrable human immunoglobuline and process for its preparation |
| US4482483A (en) * | 1983-04-06 | 1984-11-13 | Armour Pharmceutical Company | Composition of intravenous immune globulin |
| SE8302483L (sv) * | 1983-05-02 | 1984-11-03 | Pharmacia Ind | Forfarande vid rening av biologiskt aktiva substanser |
| US5945098A (en) * | 1990-02-01 | 1999-08-31 | Baxter International Inc. | Stable intravenously-administrable immune globulin preparation |
| DE19907257A1 (de) * | 1999-02-21 | 2000-09-14 | Bernd Horst Meier | Mittel zur Steuerung der Diffusion von Injektionslösungen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE348942B (US07847105-20101207-C00016.png) * | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
| DE2234069A1 (de) * | 1971-07-16 | 1973-02-08 | South African Inventions | Verfahren zur herstellung eines gereinigten gamma-globulins |
| IL43643A (en) * | 1972-11-27 | 1976-10-31 | Baxter Laboratories Inc | Method for production of gamma globulin |
| JPS49101516A (US07847105-20101207-C00016.png) * | 1973-01-13 | 1974-09-25 |
-
1975
- 1975-01-02 DE DE2500076A patent/DE2500076C3/de not_active Expired
- 1975-12-16 NL NLAANVRAGE7514627,A patent/NL179824C/xx not_active IP Right Cessation
- 1975-12-18 SE SE7514388A patent/SE437470B/xx not_active IP Right Cessation
- 1975-12-22 DK DK584375A patent/DK144679C/da active
- 1975-12-23 AT AT981675A patent/AT344883B/de active
- 1975-12-26 FR FR7539814A patent/FR2296429A1/fr active Granted
- 1975-12-27 JP JP15974275A patent/JPS5512001B2/ja not_active Expired
- 1975-12-29 GB GB53020/75A patent/GB1495159A/en not_active Expired
- 1975-12-29 DD DD190614A patent/DD121875A5/xx unknown
- 1975-12-30 ES ES443982A patent/ES443982A1/es not_active Expired
- 1975-12-30 AU AU87921/75A patent/AU505416B2/en not_active Expired
- 1975-12-30 IN IN2413/CAL/75A patent/IN143525B/en unknown
- 1975-12-30 IL IL48766A patent/IL48766A/xx unknown
- 1975-12-30 IE IE2826/75A patent/IE43449B1/en unknown
- 1975-12-30 EG EG775/75A patent/EG11987A/xx active
- 1975-12-30 BE BE6045314A patent/BE837211A/xx not_active IP Right Cessation
- 1975-12-30 ZA ZA00758050A patent/ZA758050B/xx unknown
- 1975-12-30 CA CA242,734A patent/CA1058075A/en not_active Expired
- 1975-12-31 SU SU7502306354A patent/SU576898A3/ru active
-
1976
- 1976-01-01 PL PL1976186289A patent/PL99599B1/pl unknown
Cited By (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980002374A1 (en) * | 1979-05-10 | 1980-11-13 | American Hospital Supply Corp | Hydroxyalkyl starch drug carrier |
| EP0028641A1 (en) * | 1979-05-10 | 1981-05-20 | American Hospital Supply Corp | MEDICINAL PRODUCTS BASED ON HYDROXYALKYL STARCH. |
| EP0028641A4 (en) * | 1979-05-10 | 1981-09-01 | American Hospital Supply Corp | MEDICINAL PRODUCTS BASED ON HYDROXYALKYL STARCH. |
| EP0019403A3 (en) * | 1979-05-10 | 1981-10-07 | American Hospital Supply Corporation | Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal |
| EP0073371A2 (en) * | 1981-08-24 | 1983-03-09 | Miles Laboratories, Inc. | Intravenously injectable immune serum globulin and method of preparing same |
| EP0073371A3 (en) * | 1981-08-24 | 1983-09-21 | Miles Laboratories Inc. | Intravenously injectable immune serum globulin and method of preparing same |
| EP1190719A1 (de) * | 2000-08-17 | 2002-03-27 | B. Braun Melsungen Ag | Kolloidale Pharmakomodulation injizierter Arzneimittel |
| US10464976B2 (en) | 2003-01-31 | 2019-11-05 | AbbVie Deutschland GmbH & Co. KG | Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| US9176150B2 (en) | 2003-01-31 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| US8497072B2 (en) | 2005-11-30 | 2013-07-30 | Abbott Laboratories | Amyloid-beta globulomer antibodies |
| US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
| US10538581B2 (en) | 2005-11-30 | 2020-01-21 | Abbvie Inc. | Anti-Aβ globulomer 4D10 antibodies |
| US10323084B2 (en) | 2005-11-30 | 2019-06-18 | Abbvie Inc. | Monoclonal antibodies against amyloid beta protein and uses thereof |
| US10208109B2 (en) | 2005-11-30 | 2019-02-19 | Abbvie Inc. | Monoclonal antibodies against amyloid beta protein and uses thereof |
| US9540432B2 (en) | 2005-11-30 | 2017-01-10 | AbbVie Deutschland GmbH & Co. KG | Anti-Aβ globulomer 7C6 antibodies |
| US9951125B2 (en) | 2006-11-30 | 2018-04-24 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
| US9394360B2 (en) | 2006-11-30 | 2016-07-19 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
| US9359430B2 (en) | 2006-11-30 | 2016-06-07 | Abbvie Inc. | Abeta conformer selective anti-Abeta globulomer monoclonal antibodies |
| US8877190B2 (en) | 2006-11-30 | 2014-11-04 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
| US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
| US9822171B2 (en) | 2010-04-15 | 2017-11-21 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US10047121B2 (en) | 2010-08-14 | 2018-08-14 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
| US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
Also Published As
| Publication number | Publication date |
|---|---|
| ES443982A1 (es) | 1977-07-16 |
| IE43449L (en) | 1976-07-02 |
| EG11987A (en) | 1981-12-31 |
| FR2296429B1 (US07847105-20101207-C00016.png) | 1978-12-01 |
| DE2500076B2 (de) | 1979-02-22 |
| AU505416B2 (en) | 1979-11-22 |
| NL7514627A (nl) | 1976-07-06 |
| DE2500076C3 (de) | 1982-11-18 |
| DD121875A5 (US07847105-20101207-C00016.png) | 1976-09-05 |
| SE7514388L (sv) | 1976-07-05 |
| DK584375A (da) | 1976-07-03 |
| ZA758050B (en) | 1976-12-29 |
| CA1058075A (en) | 1979-07-10 |
| JPS5512001B2 (en) | 1980-03-29 |
| IN143525B (US07847105-20101207-C00016.png) | 1977-12-17 |
| BE837211A (fr) | 1976-06-30 |
| PL99599B1 (pl) | 1978-07-31 |
| SE437470B (sv) | 1985-03-04 |
| IE43449B1 (en) | 1981-02-25 |
| IL48766A (en) | 1979-11-30 |
| FR2296429A1 (fr) | 1976-07-30 |
| IL48766A0 (en) | 1976-02-29 |
| DK144679B (da) | 1982-05-10 |
| AU8792175A (en) | 1977-07-14 |
| AT344883B (de) | 1978-08-10 |
| DE2500076A1 (de) | 1976-07-08 |
| DK144679C (da) | 1982-10-11 |
| ATA981675A (de) | 1977-12-15 |
| NL179824B (nl) | 1986-06-16 |
| NL179824C (nl) | 1986-11-17 |
| SU576898A3 (ru) | 1977-10-15 |
| JPS5191321A (en) | 1976-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1495159A (en) | Process reducing the anticomplementary activity of gamma globulins | |
| Chazotte et al. | Further studies on F1-ATPase inhibition by local anesthetics | |
| ES8506758A1 (es) | Un procedimiento para preparar un compuesto de oclusion de 2-nitroximetil-6-cloropiridina | |
| GB1418849A (en) | Production of antisera | |
| GB1473245A (en) | Purification of plasminogen | |
| GB1480700A (en) | Rifamycin s and sv derivatives | |
| GB779493A (en) | Process for the isolation of stable, highly purified gamma globulin preparations | |
| GB1312391A (en) | Basically substituted 4 3h- quinazolinone derivatives and process for their manufacture | |
| GB1528259A (en) | Process for the preparation of a gamma-globulin solution suitable for intravenous administration | |
| IE42521L (en) | Treating a sodium lauryl sulphate-whey protein complex. | |
| GB1421006A (en) | Imidazolidine derivatives | |
| DE3687995D1 (de) | Verfahren zur reinigung von interferon und so hergestellte zusammensetzung. | |
| GB1436529A (en) | Process for preparing a blood fraction | |
| DE3483784D1 (de) | Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung. | |
| GB1469908A (en) | Preparation containing an enzyme for removal of anti-complement from gamma globulin | |
| GB1377596A (en) | Process for the preparation of 1-substituted 3-hydroxypyrazoles | |
| GB1290381A (US07847105-20101207-C00016.png) | ||
| GB1243953A (en) | Benzdiazepine derivatives | |
| GB1253328A (en) | PURIFICATION OF gamma GLOBULIN | |
| GB967594A (en) | 2-(2,6-dimethyl-3-hydroxy-4-tert-butyl-benzyl)-2-imidazoline,and acid addition salts thereof,and process for their manufacture | |
| DE2311333C2 (de) | Verfahren zur Herstellung eines intravenös injizierbaren modifizierten Immunserumglobulins | |
| GB1475262A (en) | Human urinary trypsin inhibitor and a method of preparing it | |
| GB1222294A (en) | Oxazinobenzodiazepine derivatives | |
| GB1384684A (en) | 1,3,5-triazine and process for the preparation thereof | |
| GB1377998A (en) | Pharmaceutical preparations for the treatment of pubertas praecox |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19951228 |